TMPRSS2-ERG fusion
|
Prostate Cancer
|
TMPRSS2-ERG fusion
|
Prostate Cancer
|
radium Ra-223 dichloride Resistant: C3 – Early Trials
Prostate - 3 weeks (New C3)
|
radium Ra-223 dichloride Resistant: C3 – Early Trials
Prostate - 3 weeks - (New C3)
|
TMPRSS2-ERG fusion
|
Prostate Cancer
|
TMPRSS2-ERG fusion
|
Prostate Cancer
|
docetaxel Resistant: C3 – Early Trials
|
docetaxel Resistant: C3 – Early Trials
|
TMPRSS2-ERG fusion
|
Prostate Cancer
|
TMPRSS2-ERG fusion
|
Prostate Cancer
|
rucaparib Sensitive: D – Preclinical
|
rucaparib Sensitive: D – Preclinical
|